13 results on '"Malladi N"'
Search Results
2. Microscopic Techniques for the Analysis of Micro and Nanostructures of Biopolymers and Their Derivatives
- Author
-
Abhilash Venkateshaiah, Vinod V.T. Padil, Malladi Nagalakshmaiah, Stanisław Waclawek, Miroslav Černík, and Rajender S. Varma
- Subjects
biopolymers ,microstructures ,nanostructures ,surface morphology ,filler dispersion ,chemical composition ,optical microscopy ,scanning electron microscopy ,transmission electron microscopy ,atomic force microscopy ,Organic chemistry ,QD241-441 - Abstract
Natural biopolymers, a class of materials extracted from renewable sources, is garnering interest due to growing concerns over environmental safety; biopolymers have the advantage of biocompatibility and biodegradability, an imperative requirement. The synthesis of nanoparticles and nanofibers from biopolymers provides a green platform relative to the conventional methods that use hazardous chemicals. However, it is challenging to characterize these nanoparticles and fibers due to the variation in size, shape, and morphology. In order to evaluate these properties, microscopic techniques such as optical microscopy, atomic force microscopy (AFM), and transmission electron microscopy (TEM) are essential. With the advent of new biopolymer systems, it is necessary to obtain insights into the fundamental structures of these systems to determine their structural, physical, and morphological properties, which play a vital role in defining their performance and applications. Microscopic techniques perform a decisive role in revealing intricate details, which assists in the appraisal of microstructure, surface morphology, chemical composition, and interfacial properties. This review highlights the significance of various microscopic techniques incorporating the literature details that help characterize biopolymers and their derivatives.
- Published
- 2020
- Full Text
- View/download PDF
3. Paricalcitol attenuates oxidative stress and inflammatory response in the liver of NAFLD rats by regulating FOXO3a and NFκB acetylation.
- Author
-
Malladi N, Lahamge D, Somwanshi BS, Tiwari V, Deshmukh K, Balani JK, Chakraborty S, Alam MJ, and Banerjee SK
- Subjects
- Animals, Acetylation drug effects, Humans, Male, Rats, Hep G2 Cells, Inflammation metabolism, Sirtuin 1 metabolism, Diet, High-Fat adverse effects, Rats, Sprague-Dawley, Sirtuins, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease drug therapy, Oxidative Stress drug effects, Forkhead Box Protein O3 metabolism, Forkhead Box Protein O3 genetics, NF-kappa B metabolism, Ergocalciferols pharmacology, Ergocalciferols therapeutic use, Liver metabolism, Liver drug effects
- Abstract
The lack of therapeutics along with complex pathophysiology made non-alcoholic fatty liver disease (NAFLD) a research hotspot. Studies showed that the deficiency of Vitamin D plays a vital role in NAFLD pathogenesis. While several research studies focused on vitamin D supplementation in NAFLD, there is still a need to understand the regulatory mechanism of direct vitamin D receptor activation in NAFLD. In the present study, we explored the role of direct Vitamin D receptor activation using paricalcitol in choline-deficient high-fat diet-induced NAFLD rat liver and its modulation on protein acetylation. Our results showed that paricalcitol administration significantly reduced the fat accumulation in HepG2 cells and the liver of NAFLD rats. Paricalcitol attenuated the elevated serum level of alanine transaminase, aspartate transaminase, insulin, low-density lipoprotein, triglyceride, and increased high-density lipoprotein in NAFLD rats. Paricalcitol significantly decreased the increased total protein acetylation by enhancing the SIRT1 and SIRT3 expression in NAFLD liver. Further, the study revealed that paricalcitol reduced the acetylation of NFκB and FOXO3a in NAFLD liver along with a decrease in the mRNA expression of IL1β, NFκB, TNFα, and increased catalase and MnSOD. Moreover, total antioxidant activity, glutathione, and catalase were also elevated, whereas lipid peroxidation, myeloperoxidase, and reactive oxygen species levels were significantly decreased in the liver of NAFLD after paricalcitol administration. The study concludes that the downregulation of SIRT1 and SIRT3 in NAFLD liver was associated with an increased acetylated NFκB and FOXO3a. Paricalcitol effectively reversed hepatic inflammation and oxidative stress in NAFLD rats through transcriptional regulation of NFκB and FOXO3a, respectively, by inhibiting their acetylation., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Correction: Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast.
- Author
-
Tariq U, Sarkar S, Malladi N, Kumar R, Bugga P, Chakraborty P, and Banerjee SK
- Published
- 2024
- Full Text
- View/download PDF
5. Doxorubicin induces phosphorylation of lamin A/C and loss of nuclear membrane integrity: A novel mechanism of cardiotoxicity.
- Author
-
Tiwari V, Gupta P, Malladi N, Salgar S, and Banerjee SK
- Subjects
- Animals, Phosphorylation drug effects, Rats, Cell Line, Myocytes, Cardiac metabolism, Myocytes, Cardiac drug effects, Myocytes, Cardiac pathology, Antibiotics, Antineoplastic toxicity, Male, Rats, Sprague-Dawley, Doxorubicin toxicity, Lamin Type A metabolism, Lamin Type A genetics, Nuclear Envelope metabolism, Nuclear Envelope drug effects, Cardiotoxicity metabolism, Cardiotoxicity pathology, Cardiotoxicity etiology
- Abstract
Lamin A/C, essential inner nuclear membrane proteins, have been linked to progeria, a disease of accelerated aging, and many other diseases, which include cardiac disorder. Lamin A/C mutation and its phosphorylation are associated with altering nuclear shape and size. The role of lamin A/C in regulating normal cardiac function was reported earlier. In the present study, we hypothesized that Doxorubicin (Dox) may alter total lamin A/C expression and phosphorylation, thereby taking part in cardiac injury. An in vitro cellular injury model was generated with Dox (0.1-10.0 μM) treatment on cardiomyoblast cells (H9c2) to prove our hypothesis. Increased size and irregular (ameboid) nucleus shape were observed in H9c2 cells after Dox treatment. Similarly, we have observed a significant increase in cell death on increasing the Dox concentration. The expression of lamin A/C and its phosphorylation at serine 22 significantly decreased and increased, respectively in H9c2 cells and rat hearts after Dox exposure. Phosphorylation led to depolymerization of the lamin A/C in the inner nuclear membrane and was evidenced by their presence throughout the nucleoplasm as observed by immunocytochemistry techniques. Thinning and perforation on the walls of the nuclear membrane were observed in Dox-treated H9c2 cells. LMNA-overexpression in H9c2 protected the cells from Dox-induced cell death, reversing all changes described above. Further, improvement of lamin A/C levels was observed in Dox-treated H9c2 cells when treated with Purvalanol A, a CDK1 inhibitor and N-acetylcysteine, an antioxidant. The study provides new insight regarding Dox-induced cardiac injury with the involvement of lamin A/C and alteration of inner nuclear membrane structure., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
6. Knockdown of SCN5A alters metabolic-associated genes and aggravates hypertrophy in the cardiomyoblast.
- Author
-
Tariq U, Sarkar S, Malladi N, Kumar R, Bugga P, Chakraborty P, and Banerjee SK
- Subjects
- Rats, Cell Line, Myocytes, Cardiac metabolism, Natriuretic Peptide, Brain genetics, Natriuretic Peptide, Brain metabolism, Animals, Gene Knockdown Techniques, Humans, Myoblasts, Cardiac metabolism, Energy Metabolism genetics, Gene Expression Regulation genetics, NAV1.5 Voltage-Gated Sodium Channel genetics, NAV1.5 Voltage-Gated Sodium Channel metabolism, Cardiomegaly genetics, Cardiomegaly metabolism, Isoproterenol pharmacology
- Abstract
SCN5A mutations have been reported to cause various cardiomyopathies in humans. Most of the SCN5A mutations causes loss of function and thereby, alters the overall cellular function. Therefore, to understand the loss of SCN5A function in cardiomyocytes, we have knocked down the SCN5A gene (SCN5A-KD) in H9c2 cells and explored the cell phenotype and molecular behaviors in the presence and absence of isoproterenol (ISO), an adrenergic receptor agonist that induces cardiac hypertrophy. Expression of several genes related to hypertrophy, inflammation, fibrosis, and energy metabolism pathways were evaluated. It was found that the mRNA expression of hypertrophy-related gene, brain (B-type) natriuretic peptide (BNP) was significantly increased in SCN5A-KD cells as compared to 'control' H9c2 cells. There was a further increase in the mRNA expressions of BNP and βMHC in SCN5A-KD cells after ISO treatment compared to their respective controls. Pro-inflammatory cytokine, tumor necrosis factor-alpha expression was significantly increased in 'SCN5A-KD' H9c2 cells. Further, metabolism-related genes like glucose transporter type 4, cluster of differentiation 36, peroxisome proliferator-activated receptor alpha, and peroxisome proliferator-activated receptor-gamma were significantly elevated in the SCN5A-KD cells as compared to the control cells. Upregulation of these metabolic genes is associated with increased ATP production. The study revealed that SCN5A knock-down causes alteration of gene expression related to cardiac hypertrophy, inflammation, and energy metabolism pathways, which may promote cardiac remodelling and cardiomyopathy., (© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2024
- Full Text
- View/download PDF
7. The role of platelets in non-alcoholic fatty liver disease: From pathophysiology to therapeutics.
- Author
-
Malladi N, Alam MJ, Maulik SK, and Banerjee SK
- Subjects
- Humans, Platelet Aggregation Inhibitors therapeutic use, Blood Platelets, Platelet Activation, Liver, Non-alcoholic Fatty Liver Disease complications, Non-alcoholic Fatty Liver Disease drug therapy, Thrombosis
- Abstract
Platelets are one of the key mediators in thrombosis as well as in the progression of many diseases. An increase in platelet activation and a decrease in platelet count is associated with a plethora of liver diseases. In non-alcoholic fatty liver disease (NAFLD), platelets are highly activated and participate in the disease progression by enhancing the pro-thrombotic and pro-inflammatory state. Some altered platelet parameters such as mean platelet volume, plateletcrits, and platelet distribution width, aspartate transaminase to platelet ratio index, liver stiffness to platelet ratio and red cell distribution width to platelet ratio were found to be associated with NAFLD disease. Further, platelet contributes to the progression of cardiovascular complications in NAFLD is gaining the researcher's attention. An elevated mean platelet volume is known to enhance the risk of stroke, atherosclerosis, thrombosis, and myocardial infarction in NAFLD. Evidence also suggested that modulation in platelet function using aspirin, ticlopidine, and cilostazol help in controlling the NAFLD progression. Future research should focus on antiplatelet therapy as a treatment strategy that can control platelet activation in NAFLD as well as its cardiovascular risk. In the present review, we have detailed the role of platelets in NAFLD and its cardiovascular complications. We further aimed to highlight the growing need for antiplatelet therapy in NAFLD., Competing Interests: Conflict of interest The authors declare no conflict of interests., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
8. Understanding the Activation of Platelets in Diabetes and Its Modulation by Allyl Methyl Sulfide, an Active Metabolite of Garlic.
- Author
-
Malladi N, Johny E, Uppulapu SK, Tiwari V, Alam MJ, Adela R, and Banerjee SK
- Subjects
- Allyl Compounds metabolism, Allyl Compounds therapeutic use, Analysis of Variance, Animals, Diabetes Mellitus, Type 1 blood, Diabetes Mellitus, Type 1 physiopathology, Disease Models, Animal, Flow Cytometry methods, Flow Cytometry statistics & numerical data, Garlic metabolism, Platelet Activation physiology, Rats, Sulfides metabolism, Sulfides therapeutic use, Allyl Compounds pharmacology, Diabetes Mellitus, Type 1 drug therapy, Platelet Activation drug effects, Sulfides pharmacology
- Abstract
Background: Diabetes mellitus (DM) is a chronic metabolic disorder associated with higher risk of having cardiovascular disease. Platelets play a promising role in the pathogenesis of cardiovascular complications in diabetes. Since last several decades, garlic and its bioactive components are extensively studied in diabetes and its complications. Our aim was to explore the antiplatelet property of allyl methyl sulfide (AMS) focusing on ameliorating platelet activation in diabetes., Method: We used streptozotocin- (STZ-) induced diabetic rats as model for type 1 diabetes. We have evaluated the effect of allyl methyl sulfide on platelet activation by administrating AMS to diabetic rats for 10 weeks. Flow cytometry-based analysis was used to evaluate the platelet activation, platelet aggregation, platelet macrophage interaction, and endogenous ROS generation in the platelets obtained from control, diabetes, and AMS- and aspirin-treated diabetic rats., Results: AMS treatment for 10 weeks effectively reduced the blood glucose levels in diabetic rats. Three weeks of AMS (50 mg/kg/day) treatment did not reduce the activation of platelets but a significant ( p < 0.05) decrease was observed after 10 weeks of treatment. Oral administration of AMS significantly ( p < 0.05) reduced the baseline and also reduced ADP-induced aggregation of platelets after 3 and 10 weeks of treatment. Furthermore, 10 weeks of AMS treatment in diabetic rats attenuated the endogenous ROS content ( p < 0.05) of platelets and platelet macrophage interactions. The inhibition of platelet activation in diabetic rats after AMS treatment was comparable with aspirin treatment (30 mg/kg/day)., Conclusion: We observed an inhibitory effect of allyl methyl sulfide on platelet aggregation, platelet activation, platelet macrophage interaction, and increased ROS levels in type 1 diabetes. Our data suggests that AMS can be useful to control cardiovascular complication in diabetes via inhibition of platelet activation., Competing Interests: The authors declare that there is no conflict of interest regarding the publication of this paper., (Copyright © 2021 Navya Malladi et al.)
- Published
- 2021
- Full Text
- View/download PDF
9. Dermoscopic features of various stages of lichen planus.
- Author
-
Makhecha M, Singh T, Malladi N, and Rambhia K
- Subjects
- Cross-Sectional Studies, Humans, Dermoscopy methods, Lichen Planus classification, Lichen Planus diagnosis
- Abstract
Competing Interests: None
- Published
- 2020
- Full Text
- View/download PDF
10. Perianal Eccrine Syringofibroadenoma.
- Author
-
Dongre AM, Nikam VV, Pathave HS, and Malladi N
- Abstract
Eccrine syringofibroadenoma (ESFA) is a rare eccrine ductal adnexal tumor. It shows variable presentations as solitary or multiple nodular lesions arranged in different patterns. It is most commonly seen in middle-aged to elderly patients, and most common sites include the extremities. Classic histopathological findings show anastomosing cords and strands of uniform cuboidal cells surrounded by fibrovascular stroma. Herein, we report a case of reactive ESFA which developed on the perianal region of a 31-year-old man., Competing Interests: There are no conflicts of interest. What is new? Perianal nodules presenting as syringofibroadenoma is rare presentation of this uncommon tumour. No such prior associations have been documented prior to this report
- Published
- 2017
- Full Text
- View/download PDF
11. Interdisciplinary rehabilitation.
- Author
-
Malladi N
- Subjects
- Evidence-Based Medicine, Humans, Pain Management, Pain Measurement, United States, Chronic Pain rehabilitation, Delivery of Health Care, Integrated
- Abstract
Interdisciplinary pain rehabilitation programs are infrequently used in the United States in the treatment of chronic pain. Comprehensively addressing the contributors to chronic pain, which include behavioral, psychological, and physical dimensions, has shown evidence-based efficacy in improving functioning and reducing pain-related distress. This approach also holds the potential for reducing the escalating costs of chronic pain care., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
12. Correlation between the combined sensory index and clinical outcome after carpal tunnel decompression: a retrospective review.
- Author
-
Malladi N, Micklesen PJ, Hou J, and Robinson LR
- Subjects
- Female, Follow-Up Studies, Humans, Male, Neural Conduction physiology, Recovery of Function physiology, Retrospective Studies, Treatment Outcome, Carpal Tunnel Syndrome physiopathology, Carpal Tunnel Syndrome surgery, Decompression, Surgical methods, Severity of Illness Index
- Abstract
The combined sensory index (CSI) is a useful electrodiagnostic tool, but it was not known if the CSI can be correlated with clinical outcome following carpal tunnel decompression. The objective of this study was to examine the association between the CSI and symptom relief from pain and parasthesiae following surgical intervention. Retrospective chart review was performed on 272 patients, diagnosed with carpal tunnel syndrome by electrodiagnostic criteria, who proceeded to undergo open or endoscopic carpal tunnel release with postoperative follow-up at an academic medical center between 1996 and 2006. The CSI demonstrated statistical significance (P = 0.03) for correlation with resolution of pain and parasthesiae following carpal tunnel decompression. Patients with a CSI of 2.5-4.6 had the best prognosis for resolution of pain and parasthesiae following surgical intervention. Median compound muscle action potential (CMAP) amplitude and median motor latency were also associated with resolution of parasthesiae, but not pain. The CSI effectively establishes correlation with clinical outcomes following surgical intervention for carpal tunnel syndrome, and thus a range of optimal outcomes (CSI between 2.5 and 4.6) can also be established.
- Published
- 2010
- Full Text
- View/download PDF
13. The ability of multi-site, multi-depth sacral lateral branch blocks to anesthetize the sacroiliac joint complex.
- Author
-
Dreyfuss P, Henning T, Malladi N, Goldstein B, and Bogduk N
- Subjects
- Arthralgia physiopathology, Arthrography methods, Bupivacaine administration & dosage, Contrast Media, Double-Blind Method, Drug Administration Schedule, Humans, Injections, Intra-Articular methods, Joint Capsule drug effects, Joint Capsule innervation, Ligaments drug effects, Ligaments innervation, Low Back Pain physiopathology, Monitoring, Intraoperative, Sacroiliac Joint innervation, Sacroiliac Joint physiopathology, Spinal Nerves physiology, Treatment Outcome, Anesthetics, Local administration & dosage, Arthralgia drug therapy, Low Back Pain drug therapy, Nerve Block methods, Sacroiliac Joint drug effects, Spinal Nerves drug effects
- Abstract
Objective: To determine the physiologic effectiveness of multi-site, multi-depth sacral lateral branch injections., Design: Double-blind, randomized, placebo-controlled study., Setting: Outpatient pain management center., Patients: Twenty asymptomatic volunteers., Background: The dorsal innervation to the sacroiliac joint (SIJ) is from the L5 dorsal ramus and the S1-3 lateral branches. Multi-site, multi-depth lateral branch blocks were developed to compensate for the complex regional anatomy that limited the effectiveness of single-site, single-depth lateral branch injections., Interventions: Bilateral multi-site, multi-depth lateral branch green dye injections and subsequent dissection on two cadavers revealed a 91% accuracy with this technique. Session 1: 20 asymptomatic subjects had a 25-g spinal needle probe their interosseous (IO) and dorsal sacroiliac (DSI) ligaments. The inferior dorsal SIJ was entered and capsular distension with contrast medium was performed. Discomfort had to occur with each provocation maneuver and a contained arthrogram was necessary to continue in the study. Session 2: 1 week later; computer randomized, double-blind multi-site, multi-depth lateral branch blocks injections were performed. Ten subjects received active (bupivicaine 0.75%) and 10 subjects received sham (normal saline) multi-site, multi-depth lateral branch injections. Thirty minutes later, provocation testing was repeated with identical methodology used in session 1., Outcome Measures: Presence or absence of pain for ligamentous probing and SIJ capsular distension., Results: Seventy percent of the active group had an insensate IO and DSI ligaments, and inferior dorsal SIJ vs 0-10% of the sham group. Twenty percent of the active vs 10% of the sham group did not feel repeat capsular distension. Six of seven subjects (86%) retained the ability to feel repeat capsular distension despite an insensate dorsal SIJ complex., Conclusion: Multi-site, multi-depth lateral branch blocks are physiologically effective at a rate of 70%. Multi-site, multi-depth lateral branch blocks do not effectively block the intra-articular portion of the SIJ. There is physiological evidence that the intra-articular portion of the SIJ is innervated from both ventral and dorsal sources. Comparative multi-site, multi-depth lateral branch blocks should be considered a potentially valuable tool to diagnose extra-articular SIJ pain and determine if lateral branch radiofrequency neurotomy may assist one with SIJ pain.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.